Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Susanne Hoerning"'
Autor:
Bruce Carleton, Susanne Hoerning, Guillermo J. Ruiz-Argüelles, Mónica Moreno-Galván, Sandra G. Heil, Elixabet Lopez-Lopez, Shakila Jabeen, Natanja Oosterom, Donato Gemmati, Anke H. Maitland-van der Zee, Rachael Windsor, Patricia Esperón, Marry M. van den Heuvel-Eibrink, Charlotte Sleurs, Hedy Maagdenberg, Oliver Zolk, Jolanda Zanen
Publikováno v:
Critical Reviews in Oncology/Hematology. 161
Methotrexate (MTX), an important chemotherapeutic agent, is often accompanied with mucositis. The occurrence and severity are unpredictable and show large interindividual variability. In this study, we review and meta-analyze previously studied genet
Autor:
Sandra G. Heil, Marissa A. H. den Hoed, Marry M. van den Heuvel-Eibrink, Rob Pieters, Saskia M F Pluijm, Oliver Zolk, Marijn Berrevoets, Robert de Jonge, Susanne Hoerning, Natanja Oosterom, Wim J. E. Tissing
Publikováno v:
PHARMACOGENETICS AND GENOMICS, 28(10), 223-229. LIPPINCOTT WILLIAMS & WILKINS
Oosterom, N, Berrevoets, M, den Hoed, M A H, Zolk, O, Hoerning, S, Pluijm, S M F, Pieters, R, de Jonge, R, Tissing, W J E, van den Heuvel-Eibrink, M M & Heil, S G 2018, ' The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia ', Pharmacogenetics and Genomics, vol. 28, no. 10, pp. 223-229 . https://doi.org/10.1097/FPC.0000000000000352
Pharmacogenetics Genomics, 28(10), 223-229. Lippincott Williams & Wilkins
Pharmacogenetics and Genomics, 28(10), 223-229. Lippincott Williams and Wilkins Ltd.
Oosterom, N, Berrevoets, M, den Hoed, M A H, Zolk, O, Hoerning, S, Pluijm, S M F, Pieters, R, de Jonge, R, Tissing, W J E, van den Heuvel-Eibrink, M M & Heil, S G 2018, ' The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia ', Pharmacogenetics and Genomics, vol. 28, no. 10, pp. 223-229 . https://doi.org/10.1097/FPC.0000000000000352
Pharmacogenetics Genomics, 28(10), 223-229. Lippincott Williams & Wilkins
Pharmacogenetics and Genomics, 28(10), 223-229. Lippincott Williams and Wilkins Ltd.
Objective Methotrexate (MTX) is an important drug in the treatment of pediatric acute lymphoblastic leukemia (ALL). MTX is cytotoxic as it impairs DNA and RNA synthesis by inhibiting the enzymes dihydrofolate reductase (DHFR) and thymidylate synthase